Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals
ABSTRACT Increases in bone mineral density (BMD) with osteoporosis treatment are associated with reduced fracture risk. Increasing BMD is therefore a goal of osteoporosis therapy. Here, we compare the probability of achieving a T‐score of > −2.5 over 3 years at the total hip (TH) or lumbar spine...
Guardado en:
Autores principales: | Felicia Cosman, Cesar Libanati, Cynthia Deignan, Zhigang Yu, Zhenxun Wang, Serge Ferrari, Jens‐Erik Beck Jensen, Pilar Peris, Francesco Bertoldo, Eric Lespessailles, Eric Hesse, Steven R Cummings |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/39be35b5ab714be384692183a32a8b87 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacological Therapy of Osteoporosis: What’s New?
por: Iolascon G, et al.
Publicado: (2020) -
Trabecular Bone Score (TBS) in Patients with Early Ankylosing Spondylitis—Limited Utility
por: Anna Nowakowska-Płaza, et al.
Publicado: (2021) -
Abaloparatide and the Spine: A Narrative Review
por: Thompson JC, et al.
Publicado: (2020) -
Bone Quality and Fractures in Women With Osteoporosis Treated With Bisphosphonates for 1 to 14 Years
por: Hartmut H Malluche, et al.
Publicado: (2021) -
Effects of Nandrolone Decanoate on Spermatogenesis in Wistar Rats With and Without Physical Training
por: Maia,Bernardo Porto, et al.
Publicado: (2015)